Sort
50,496 grants matching “lung cancer”
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
$676,308George R Washko · Brigham And Women'S Hospital · R01 · FY2020 · HL
The clinical impact of longitudinal measures of cardiac and pulmonary vascular morphology in smokers
$676,308George R Washko · Brigham And Women'S Hospital · R01 · FY2021 · HL
Signal Transduction by Tyrosine Phosphorylation
$676,298Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2011 · CA
A trial of Positively Smoke Free group therapy for HIV-infected smokers
$676,287Jonathan Shuter · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DA
Enabling Ultra Low Dose PET/CT Imaging
$676,231Paul E Kinahan · University Of Washington · R01 · FY2013 · CA
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
$676,225Hak Soo Choi · Massachusetts General Hospital · R01 · FY2017 · EB
Molecular Risk Stratification for Colonoscopic Surveillance
$676,118Andrew T Chan · Massachusetts General Hospital · U01 · FY2016 · CA
Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma
$676,092Kirk Seward · Mercator Medsystems, Inc. · R42 · FY2011 · CA
Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells
$676,075Mark Jesus Magbanua · University Of California, San Francisco · R01 · FY2025 · CA
Protein interactions regulate iron storage and utilization in bacteria
$676,071Mario Rivera · University Of Kansas Center For Research Inc · · FY2016 · BIO
Antifibrotic Therapy to Improve Immune reconstitution in HIV
$676,037Timothy W Schacker · University Of Minnesota · R01 · FY2013 · AI
CCR FACS Core Laboratory
$675,994Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer
$675,960Lin Z Li · University Of Pennsylvania · R01 · FY2023 · CA
Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies
$675,834John H Kenten · Meso Scale Diagnostics, Llc · R44 · FY2009 · CA
Quantifying and Characterizing the shared genetic contribution to common cancers
$675,732Sara Lindstroem · Harvard School Of Public Health · U01 · FY2015 · CA
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
$675,718Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2022 · CA
Radiation-induced translational control of gene expression
$675,650Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$675,590Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$675,590Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Informatics Tools for Optimized Imaging Biomarkers for Cancer Research&Discovery
$675,558Jayashree Kalpathy-Cramer · Massachusetts General Hospital · U24 · FY2018 · CA
Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction
$675,462Gal Shafirstein · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
NANOPHOTOSENSITIZERS FOR REGENERATIVE PHOTOTHERAPY
$675,432Samuel Achilefu · Ut Southwestern Medical Center · R01 · FY2025 · CA
Lung cancer in never smokers: incidence, risk factors, and molecular characteristics in Asian American, Native Hawaiian and Pacific Islanderfemales
$675,424Scarlett L Gomez · University Of California, San Francisco · R01 · FY2018 · CA
CHARGE consortium: gene discovery for CVD and aging phenotypes
$675,343Bruce M Psaty · University Of Washington · R01 · FY2021 · HL
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
$675,089Roger Vilardaga · Wake Forest University Health Sciences · R01 · FY2024 · CA